expressed within adipose tissues, and to a lesser level in liver, spleen, kidney, heart and skeletal 28 muscle [10, 12] . To better understand the physiological role of this 54 kDa protein in lipid 29 homeostasis, an Atgl -/-mutant mouse was generated, and study of this mouse permitted to obtained the 30 first evidences that the ATGL protein is playing an essential role in TAG hydrolysis in-vivo [13] . 31
Indeed, several phenotypes related to lipid metabolism disorder were easily observed within an Atgl 32 null mutant such as increase in body weight, fat mass, fat accumulation in non-adipose tissues, and 33 also a greater resistance to glucose and insulin. In addition, this deficiency rapidly triggered TAG 34 accumulation within cardiac muscle thus leading to cardiac dysfunction and premature death [9, 13] . 35
All these findings suggested that a new essential component was involved in central lipid metabolism, 36 and thus opening new perspectives to better control lipid metabolic disorder in patients. 37
These information prompted several teams to further investigate, during the last decade, the potential 38 Among the proteins involved in this regulation process, Plin1 (one of the five members of the perilipin 45 family (Plin1-Plin5)) CGI-58, G0S2 and PEDF are probably the most important factors impacting 46 ATGL activity [14] . Plin1 is mastering the switch from basal to stimulated lipolysis, and this is 47 mediated by its C-terminal domain which sequesters the CGI-58 protein and so prevents the action of 48 the ATGL [15] . Upon specific hormonal stimulation Plin1 is phosphorylated and releases the CGI-58 49 co-activator protein which binds to ATGL and leads to its translocation at the LDs surface [15] . Point 50 mutations, insertions or deletions within the cgi-58 gene trigger a drastic neutral lipid storage disorder 51 also called Chanarin-Dorfman syndrome thus emphasizing the role of CGI-58 protein in LDs 52 degradation [15, 16] . In addition to CGI-58, the PEDF protein is also known for interacting with 53 ATGL and stimulating lipolysis in adipocytes [17] . In contrast to CGI-58 and PEDF which areactivators, G0S2 protein is negatively regulating ATGL activity in both in-vitro and in-vivo conditions 55 where overexpression leads to an almost identical phenotype than an Atgl -/-mutant [18] [19] [20] . 56
Another important part of their manuscript was dedicated to the inhibition of ATGL activity by either 57 natural or synthetic small molecules [14] . One of the main inhibitory mechanism towards ATGL and 58 also HSL is mediated by acyl-CoA availability within the cells [21, 22] 
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